In an univariate analysis of clinicopathological factors associated with BRCA1-mutated BC versus the WT subtype, tumor grade, ER, PR, and expression of CK5, CK14, and CLDN3 were found to be independent parameters. Here, CLDN3 is linked to breast cancer.